Afraxis
1 known investors
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $204.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Afraxis do?
- Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
- Who are Afraxis's investors?
- Afraxis's investors include Torrey Pines Investment.